A detailed history of Farther Finance Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 23,263 shares of ABBV stock, worth $4.19 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
23,263
Previous 19,721 17.96%
Holding current value
$4.19 Million
Previous $3.36 Billion 36.72%
% of portfolio
0.17%
Previous 0.16%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$163.84 - $199.33 $580,321 - $706,026
3,542 Added 17.96%
23,263 $4.59 Billion
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $218,099 - $254,690
1,409 Added 7.69%
19,721 $3.36 Billion
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $2.14 Million - $2.44 Million
13,419 Added 274.25%
18,312 $3.31 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.52 Million - $1.71 Million
11,017 Added 188.84%
16,851 $2.61 Billion
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $125,708 - $145,525
941 Added 19.23%
5,834 $870 Million
Q2 2023

May 13, 2024

BUY
$132.51 - $164.9 $119,921 - $149,234
905 Added 22.69%
4,893 $659 Million
Q2 2023

Sep 12, 2023

BUY
$132.51 - $164.9 $119,921 - $149,234
905 Added 22.69%
4,893 $659 Million
Q1 2023

May 13, 2024

SELL
$144.61 - $166.54 $1.86 Million - $2.14 Million
-12,863 Reduced 76.33%
3,988 $636 Million
Q1 2023

Sep 12, 2023

BUY
$144.61 - $166.54 $179,171 - $206,343
1,239 Added 45.07%
3,988 $636 Million
Q4 2022

Sep 11, 2023

BUY
$138.31 - $165.87 $380,214 - $455,976
2,749 New
2,749 $444 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.